These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8998920)

  • 1. [Percutaneous nephrostomy in malignant ureteral obstruction].
    Demetriou D; Sebeikat D
    Dtsch Med Wochenschr; 1996 Dec; 121(49):1526-30. PubMed ID: 8998920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
    Ekici S; Sahin A; Ozen H
    J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endo-urological drainage in urinary outflow obstruction caused by cancer].
    Stevens A; van Driel MF; Klein JP; de Ruiter AJ; Mensink HJ
    Ned Tijdschr Geneeskd; 1994 Mar; 138(10):522-5. PubMed ID: 8139712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoplastic ureteral obstruction: drainage by percutaneous nephrostomy or double J catheterization].
    Desportes L; Blanchet P; Benoît G; Lecouturier S; Langloys J; Decaux A; Di Palma M; Richard C; Jardin A
    Presse Med; 1995 Oct; 24(29):1332-6. PubMed ID: 7494843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous drainage nephrostomy in patients over 70 years of age. Apropos of 98 nephrostomies in 74 patients].
    Fournier G; Delavierre D; Le Coat R; Philippe P; Mangin P
    Prog Urol; 1994 Jun; 4(3):362-70. PubMed ID: 8044179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Palliative diversion using an autostatic ureteral stent after endoscopic resection of the ureteral meatus in T4 pelvic tumors].
    Flam T; Géraud M; Zerbib M; Debré B; Steg A
    Ann Urol (Paris); 1990; 24(6):530-2. PubMed ID: 1702963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintaining quality of life after palliative diversion for malignant ureteral obstruction.
    Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC
    Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percutaneous nephrostomy].
    Hirao Y; Morita N; Yoshikawa M; Samma S; Maruyama Y; Aoyama H; Babaya K; Okajima E; Ohara S; Suemori T
    Hinyokika Kiyo; 1985 Jul; 31(7):1281-6. PubMed ID: 3904364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of transurethral resection in cancer of the prostate].
    Rodríguez JV; Chechile G
    Arch Esp Urol; 1989; 42 Suppl 2():165-77. PubMed ID: 2639620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On malignant obstructive uremia].
    Sesenna R; Bartolotta G; Brunetti A
    Arch Ital Urol Nefrol; 1970; 43(1):7-16. PubMed ID: 5495712
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant ureteral obstruction: outcomes after intervention. Have things changed?
    Wong LM; Cleeve LK; Milner AD; Pitman AG
    J Urol; 2007 Jul; 178(1):178-83; discussion 183. PubMed ID: 17499300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endoluminal therapy for bilateral malignant ureteric obstruction].
    Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of spontaneous peripelvic extravasation].
    Okumura A; Fujiuchi Y; Yokoyama T; Norisugi O; Watanabe A; Fuse H
    Hinyokika Kiyo; 2000 May; 46(5):297-300. PubMed ID: 10876749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.